Business · 17/12/2015Updated: 10/17/2026 · 1 min read
FDA Announces Proposed Collection of Information for Clinical Investigations Oversight
Summary
The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance, focusing on clinical investigations oversight, as part of a risk-based approach to monitoring.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →